IQVIA Selects Veeva Clinical Operations Applications
PR Newswire•13/10/2026•07:03 ET
0
Key Highlights
- ➤IQVIA selects Veeva CTMS, eTMF, Study Startup, and Site Connect as enterprise standards
- ➤Expanded partnership extends previously announced Veeva EDC collaboration across IQVIA clinical studies
- ➤IQVIA and Veeva aim to increase trial speed, efficiency, and site-centricity
- ➤Customers retain flexibility to choose EDC, RTSM, and eCOA technologies and solutions
Expert Statements
Richard Staub, President of Research and Development Solutions at IQVIA
“By bringing our companies' strengths together, we're giving clinical teams a more connected way to work, built on frictionless integration of our respective technologies”
Richard Staub, President of Research and Development Solutions at IQVIA
“Just as importantly, customers retain the flexibility to choose the EDC, RTSM, and eCOA technologies and solutions that best meet their needs, including IQVIA's innovative capabilities.”
Peter Gassner, Founder and CEO of Veeva Systems
“This is an exciting expansion of the partnership IQVIA and Veeva announced last year and the work we have done together since”
Peter Gassner, Founder and CEO of Veeva Systems
“We are committed to supporting seamless product and services integration for the benefit of our customers and improving access to innovations for patients.”
IQVIA Selects Veeva Clinical Operations Applications PR Newswire
RESEARCH TRIANGLE PARK, N.C. and PLEASANTON, Calif., Oct. 13, 2026
Get started
Create a free account to read the full story.